Search Results - "Ess, S. M."

Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non‐small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices by Ess, S.M., Herrmann, C., Frick, H., Krapf, M., Cerny, T., Jochum, W., Früh, M.

“…In order to improve outcomes, identification of the epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) genes has become crucial in…”
Get full text

Surgical treatment of early stage breast cancer in elderly: an international comparison by Kiderlen, M., Bastiaannet, E., Walsh, P. M., Keating, N. L., Schrodi, S., Engel, J., van de Water, W., Ess, S. M., van Eycken, L., Miranda, A., de Munck, L., van de Velde, C. J. H., de Craen, A. J. M., Liefers, G. J.

“…Over 40% of breast cancer patients are diagnosed above the age of 65. Treatment of these elderly patients will probably vary over countries. The aim of this…”
Get full text

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project by Sant, Milena, Allemani, Claudia, Tereanu, Carmen, De Angelis, Roberta, Capocaccia, Riccardo, Visser, Otto, Marcos-Gragera, Rafael, Maynadié, Marc, Simonetti, Arianna, Lutz, Jean-Michel, Berrino, Franco

“…Changing definitions and classifications of hematologic malignancies (HMs) complicate incidence comparisons. HAEMACARE classified HMs into groupings consistent…”
Get full text

Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project by Stiller, C.A, Trama, A, Serraino, D, Rossi, S, Navarro, C, Chirlaque, M.D, Casali, P.G

“…Abstract Sarcomas are a heterogeneous group of malignant neoplasms arising from mesenchymal cells which encompass dozens of histological types and can occur in…”
Get full text

Rare cancers are not so rare: The rare cancer burden in Europe by Gatta, Gemma, van der Zwan, Jan Maarten, Casali, Paolo G, Siesling, Sabine, Dei Tos, Angelo Paolo, Kunkler, Ian, Otter, Renée, Licitra, Lisa, Mallone, Sandra, Tavilla, Andrea, Trama, Annalisa, Capocaccia, Riccardo

“…Abstract Purpose Epidemiologic information on rare cancers is scarce. The project Surveillance of Rare Cancers in Europe (RARECARE) provides estimates of the…”
Get full text

Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001 by Ess, SM

Get full text

Epidemiology of glial and non-glial brain tumours in Europe by Crocetti, Emanuele, Trama, Annalisa, Stiller, Charles, Caldarella, Adele, Soffietti, Riccardo, Jaal, Jana, Weber, Damien C, Ricardi, Umberto, Slowinski, Jerzy, Brandes, Alba

“…Abstract To the central nervous system (CNS) belong a heterogeneous group of glial and non glial rare cancers. The aim of the present study was to estimate the…”
Get full text

Economic Evaluation of Immunization Strategies by Ericsson, Charles D., Steffen, Robert, Ess, Silvia M., Szucs, Thomas D.

“…Resources used to provide health care are vast but not limitless. When clinicians are asked to participate in decisions for large groups of patients (in a…”
Get full text

Incidence, survival and prevalence of myeloid malignancies in Europe by Visser, O, Trama, A, Maynadié, M, Stiller, C, Marcos-Gragera, R, De Angelis, R, Mallone, S, Tereanu, C, Allemani, C, Ricardi, U, Schouten, H.C

“…Abstract Background The Surveillance of Rare Cancers in Europe (RARECARE) project aims at increasing knowledge of rare cancers in Europe. This manuscript…”
Get full text

Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project by van der Zwan, Jan Maarten, Trama, Annalisa, Otter, Renée, Larrañaga, Nerea, Tavilla, Andrea, Marcos-Gragera, Rafael, Dei Tos, Angelo Paolo, Baudin, Eric, Poston, Graeme, Links, Thera

“…Abstract Because of the low incidence, and limited opportunities for large patient volume experiences, there are very few relevant studies of neuroendocrine…”
Get full text

Incidence and survival of rare urogenital cancers in Europe by Visser, O, Adolfsson, J, Rossi, S, Verne, J, Gatta, G, Maffezzini, M, Franks, K.N

“…Abstract Background The RARECARE project aims at increasing knowledge of rare cancers in Europe. This manuscript describes the epidemiology (incidence,…”
Get full text

Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe by Mallone, S, De Vries, E, Guzzo, M, Midena, E, Verne, J, Coebergh, J.W, Marcos-Gragera, R, Ardanaz, E, Martinez, R, Chirlaque, M.D, Navarro, C, Virgili, G

“…Abstract This work provides descriptive epidemiological data of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe as defined as in…”
Get full text

Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000–2002 by Allemani, Claudia, Minicozzi, Pamela, Berrino, Franco, Bastiaannet, Esther, Gavin, Anna, Galceran, Jaume, Ameijide, Alberto, Siesling, Sabine, Mangone, Lucia, Ardanaz, Eva, Hédelin, Guy, Mateos, Antonio, Micheli, Andrea, Sant, Milena

“…Few studies have addressed longer‐term survival for breast cancer in European women. We have made predictions of 10‐year survival for European women diagnosed…”
Get full text

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study by Maynadié, Marc, De Angelis, Roberta, Marcos-Gragera, Rafael, Visser, Otto, Allemani, Claudia, Tereanu, Carmen, Capocaccia, Riccardo, Giacomin, Adriano, Lutz, Jean-Michel, Martos, Carmen, Sankila, Risto, Johannesen, Tom Børge, Simonetti, Arianna, Sant, Milena

“…Population-based information on the survival of patients with myeloid malignancies is rare mainly because some entities were not recognized as malignant until…”
Get full text

Rare cancers of the head and neck area in Europe by Van Dijk, B.A.C, Gatta, G, Capocaccia, R, Pierannunzio, D, Strojan, P, Licitra, L

“…Abstract The RARECARE project has proposed a different and more detailed grouping of cancers, based on localisation and histological type, in order to identify…”
Get full text

Carcinoma of endocrine organs: Results of the RARECARE project by van der Zwan, Jan Maarten, Mallone, Sandra, van Dijk, Boukje, Bielska-Lasota, Magdalena, Otter, Renée, Foschi, Roberto, Baudin, Eric, Links, Thera P

“…Abstract The rarity or the asymptomatic character of endocrine tumours results in a lack of epidemiological studies on their incidence and survival patterns…”
Get full text

Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study by Bielska-Lasota, Magdalena, Rossi, Silvia, Krzyżak, Michalina, Haelens, Annemie, Domenic, Augius, De Angelis, Roberta, Maciejczyk, Adam, Rodríguez-Barranco, Miguel, Zadnik, Vesna, Minicozzi, Pamela

“…Purpose With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burden decreased in several European countries. In Eastern…”
Get full text

Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002 by Faivre, J, Trama, A, De Angelis, R, Elferink, M, Siesling, S, Audisio, R, Bosset, J.F, Cervantes, A, Lepage, C

“…Abstract Background and aims Little is known about the epidemiology of rare epithelial digestive cancers. The aim of this study was to report on their…”
Get full text

Embryonal cancers in Europe by Gatta, Gemma, Ferrari, Andrea, Stiller, Charles A, Pastore, Guido, Bisogno, Gianni, Trama, Annalisa, Capocaccia, Riccardo

“…Abstract Embryonal cancers are a heterogeneous group of rare cancers which mainly occur in children and adolescents. The aim of the present study was to…”
Get full text

Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project by Stiller, C.A, Trama, A, Brewster, D.H, Verne, J, Bouchardy, C, Navarro, C, Chirlaque, M.D, Marcos-Gragera, R, Visser, O, Serraino, D, Weiderpass, E, Dei Tos, A.P, Ascoli, V

“…Highlights • We analysed cancer registry data on Kaposi sarcoma (KS) from 21 European countries. • We used age at diagnosis to distinguish AIDS-related (<65y)…”
Get full text